A cross-site, comparative effectiveness study of an integrated HIV and substance use treatment program

AIDS Patient Care and STDs

Volumn 24, Issue 10, 2010, Pages 651-658

  Proeschold Bell, Rae Jean ^a   Heine, Amy ^b   Pence, Brian Wells ^a   McAdam, Keith ^a   Quinlivan, Evelyn Byrd ^b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

AGE DISTRIBUTION; ALCOHOLISM; ANTIVIRAL THERAPY; ARTICLE; CANNABIS ADDICTION; CLINICAL EFFECTIVENESS; COCAINE DEPENDENCE; COGNITIVE THERAPY; DISEASE SEVERITY; DRUG DEPENDENCE TREATMENT; FEMALE; GROUP THERAPY; HEROIN DEPENDENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCOME; INTERVIEW; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; RACE DIFFERENCE; SCORING SYSTEM; SEX DIFFERENCE; SUBSTANCE ABUSE; THEORETICAL MODEL; TREATMENT DURATION;

ACADEMIC MEDICAL CENTERS; ADULT; AGED; AMBULATORY CARE FACILITIES; COMMUNITY HEALTH CENTERS; DELIVERY OF HEALTH CARE, INTEGRATED; FEMALE; HIV INFECTIONS; HUMANS; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; PROGRAM EVALUATION; SEVERITY OF ILLNESS INDEX; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77957999512     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.2010.0073     Document Type: Article

References (52)

1. Chander G, Himelhoch S, Fleishman JA, et al. HAART receipt and viral suppression among HIV-infected patients with co-occurring mental illness and illicit drug use. AIDS Care 2009;21:655-663.
2. Pence BW, Miller WC, Whetten K, et al. Prevalence of DSMIV- defined mood, anxiety, and substance use disorders in an HIV clinic in the Southeastern United States. J Acquir Immune Defic Syndr 2006;42:298-306.
3. Tegger MK, Crane HM, Tapia KA, et al. The effect of mental illness, substance use, and treatment for depression on the initiation of highly active antiretroviral therapy among HIV-infected individuals. AIDS Patient Care STDs 2008;22: 233-243.
4. Korthuis PT, Josephs JS, Fleishman JA, et al. Substance abuse treatment in human immunodeficiency virus: The role of patient-provider discussions. J Subst Abuse Treat 2008;35: 294-303.
5. Douaihy AB, Jou RJ, Gorske T, et al. Triple diagnosis: dual diagnosis and HIV disease part 2. AIDS Read 2003;13: 375-382. (Pubitemid 37012808)
6. Nijhawan A, Kim S, Rich JD. Management of HIV infection in patients with substance use problems. Curr Infect Dis Rep 2008;10:432-438.
7. Soto TA, Bell J, Pillen MB, et al. Literature on integrated HIV care: A review. AIDS Care 2004;16(Suppl 1):S43-55.
8. Douaihy AB, Jou RJ, Gorske T, et al. Triple diagnosis: dual diagnosis and HIV disease part 1. AIDS Read 2003;13: 331-341.
9. Mugavero M, Ostermann J, Whetten K, et al. Barriers to antiretroviral adherence: The importance of depression, abuse, and other traumatic events. AIDS Patient Care STDs 2006;20:418-428.
10. Hicks PL, Mulvey KP, Chander G, et al. The impact of illicit drug use and substance abuse treatment on adherence to HAART. AIDS Care 2007;19:1134-1140.
11. Tucker JS, Burnam MA, Sherborne CD, et al. Substance-use and mental health correlates of nonadherence to antiretroviral medications in a sample of patient with human immunodifficiency virus infection. Am J Med 2003;114: 573-580.
12. Beckett M, Burnam A, Collins RL, et al. Substance use and high risk sex among people with HIV: A comparison across exposure groups. AIDS Behav 2003;7:209-219.
13. Drumright LN, Strathdee SA, Little SJ, et al. Unprotected anal intercourse and substance use before and after HIV diagnosis among recently HIV-infected men who have sex with men. Sex Transm Dis 2007;34:401-407.
14. Blount A. Integrated primary care: Organizing the evidence. Fam Syst Health 2003;21:121-132.
15. Bartels SJ, Coakley EH, Zubritsky C, et al. Improving access to geriatric mental health services: A randomized trial comparing treatment engagement with integrated versus enhanced referral care for depression, anxiety, and at-risk alcohol use. Am J Psychiatry 2004;161:1455-1462.
16. Krahn D, Bartels SJ, Coakley EH, et al. PRISM-E: Comparison of integrated care and enhanced specialty referral models in depression outcomes. Psychiatr Serv 2006;57:946-953. (Pubitemid 44036224)
17. Williams J, Shore S, Meschan J. Co-location of mental health professionals in primary care settings: Three North Carolina models. Clin Pediatr 2006;45:537-543.
18. Willenbring ML. Integrating care for patients with infectious, psychiatric, and substance use disorders: Concepts and approaches. AIDS 2005;19:S227-S237.
19. Weisner C, Mertens J, Parthasarathy S, et al. Integrating primary medical care with addiction treatment: A randomized controlled trial. JAMA 2001;286:1715-1723. (Pubitemid 33010257)
20. Whetten K, Reif S, Ostermann J, et al. Improving health outcomes among individuals with HIV, mental illness, and substance use disorders in the Southeast. AIDS Care 2006;18(Suppl 1):S18-S26.
21. Zaller N, Gillani FS, Rich JD. A model of integrated primary care for HIV-positive patients with underlying substance use and mental illness. AIDS Care 2007;19:1128-1133.
22. Weaver MR, Conover CJ, Proescholdbell RJ, et al. Utilization of mental health and substance abuse care for people living with HIV/AIDS, chronic mental illness, and substance abuse disorders. J Acquir Immune Defic Syndr 2008;47:449-458.
23. Celentano D, Lucas G. Optimizing treatment outcomes in HIV-infected patients with substance abuse issues. Clin Infect Dis 2007;45:S318-S323.
24. Lucas GM, Mullen BA, Weidle PJ, et al. Directly administered antiretroviral therapy in methadone clinics is associated with improved HIV treatment outcomes, compared with outcomes among concurrent comparison groups. Clin Infect Dis 2006;42:1628-1635.
25. Rothman J, Rudnick D, Slifer M, et al. Co-located substance use treatment and HIV prevention and primary care services, New York State, 1990-1992: A model for effective service delivery to a high-risk population. J Urban Health 2007;84:226-242.
26. Winiarski MG, Beckett E, Salcedo J. Outcomes of an innercity HIV mental health programme integrated with primary care and emphasizing cultural responsiveness. AIDS Care 2005;17:747-756.
27. Strauss S, Tiburcio NJ, Munoz-Plaza C, et al. HIV care providers' implementation of routine alcohol reduction support for their patients. AIDS Patient Care STDs 2009;23: 211-218.
28. Batkis M, Treisman GJ, Angelino AF. Integrated opioid use disorder and HIV treatment: Rationale, clinical guidelines for addiction treatment, and review of interactions of antiretroviral agents and opioid agonist therapies. AIDS Patient Care STDs 2010;24:15-22.
29. Lombard F, Proescholdbell RJ, Cooper K, et al. Adaptations across clinical sites of an integrated treatment model for persons with HIV and substance abuse. AIDS Patient Care STDs 2009;23:631-638.
30. Whetten K, Reif S, Swartz M, et al. A brief mental health and substance abuse screener for persons with HIV. AIDS Patient Care STDs 2005;19:89-99.
31. Pence BW, Gaynes BN, Whetten K, et al. Validation of a brief screening instrument for substance abuse and mental illness in HIV-positive patients. J Acquir Immune Defic Syndr 2005;40:434-444.
32. Bouis S, Reif S, Whetten K, et al. An integrated, multidimensional treatment model for individuals living with HIV, mental illness, and substance abuse. Health Soc Work 2007; 32:268-278.
33. Drake RE, Essock SM, Shaner A, et al. Implementing dual diagnosis services for clients with severe mental illness. Psychiatr Serv 2001;52:469-476.
34. Bigg D. Substance use management: A harm reductionprincipled approach to assisting the relief of drug-related problems. J Psychoactive Drugs 2001;33:33-38.
35. Miller MR. Motivational interviewing: Research, practice and puzzles. Addict Behav 1996;21:835-842.
36. Miller WR. Motivational interviewing with problem drinkers. Behav Psychcother 1983;11:147-172.
37. Prochaska JO, DiClemente CC. Toward a comprehensive model of change. In Miller WR, Heather N, eds. Treating Addictive Behaviors: Processes of Change. New York: Plenum Press, 1986:3-27.
38. McLellan AT, Kushner H, Metzger D, et al. The Fifth Edition of the Addiction Severity Index. J Subst Abuse Treat 1992; 9:199-213.
39. Leonhard C, Mulvey K, Gastfriend DR, et al. The Addiction Severity Index: A field study of internal consistency and validity. J Subst Abuse Treat 2000;18:129-135.
40. Zanis DA, McLellan AT, Cnaan RA, et al. Reliability and validity of the Addiction Severity Index with a homeless sample. J Subst Abuse Treat 1994;11:541-548.
41. McGahan PL, Griffith JA, Parente R, et al. Addiction Severity Index composite scores manual 1986. www.tresearch.org/ resources/compscores/ CompositeManual.pdf (Last accessed July 28, 2010).
42. StataCorp. Stata Statistical Software: Release 10.0. College Station, TX: StataCorp LP 2007.
43. Zorn C. Generalized estimating equation models for correlated data: A review with applications. American Journal of Political Science. 2001;45:470-490.
44. Centers-for-Disease-Control-and-Prevention. HIV/AIDS and African Americans 2007. www.cdc.gov/hiv/topics/aa/ index.htm (Last accessed July 28, 2010).
45. Mee-Lee D, Shulman GD, Fishman M, et al. ASAM Patient Placement Criteria for the Treatment of Substance- Related Disorders, Second Edition-Revised (ASAM PPC-2R). American Society of Addiction Medicine, Inc., 2001.
46. Crits-Christoph P, Siqueland L, Blaine J, et al. Psychosocial treatments for cocaine dependence: National Institute on Drug Abuse Collaborative Cocaine Treatment Study. Arch Gen Psychiatry 1999;56:493-502.
47. Velasquez MM, vonSternberg K, Johnson DH, et al. Reducing sexual risk behaviors and alcohol use among HIV-positive men who have sex with men: A randomized clinical trial. J Consult Clin Psychol 2009;77:657-667.
48. Comulada WS, Weiss RE, Cumberland W, et al. Reductions in drug use among young people living with HIV. Am J Drug Alcohol Abuse 2007;33:493-501.
49. Wong FL, Rotheram-Borus J, Lightfoot M, et al. Effects of behavioral intervention on substance use among people living with HIV: The Healthy Living Project randomized controlled study. Addiction 2008;103:1206-1214.
50. Shoptaw S, Reback CJ, Larkins S, et al. Outcomes using two tailored behavioral treatments for substance abuse in urban gay and bisexual men. J Subst Abuse Treat 2008;35:285-293.
51. Lehman WEK, Greener JM, Simpson DD. Assessing organizational readiness for change. J Subst Abuse Treat 2002; 22:197-209.
52. Davis TF. From pilot to mainstream: Promoting collaboration between mental health and medicine. Families Syst Health 2001;19:37-45.